UBS Group AG

Position in INM — InMed Pharmaceuticals Inc.

CIK 1610520 ZURICH, V8

Position in INM

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$5,203

+$4,804 QoQ

Shares Held

8,068

+2040.1% QoQ

Ownership

0.243%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

UBS Group AG holds $1,523,030,111 across 81 Drug Manufacturers - Specialty & Generic names. INM ranks #64 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	2,799,543	$330,933,975
2	ELAN	Elanco Animal Health Inc	8,572,057	$205,129,322
3	NBIX	Neurocrine Biosciences Inc	1,221,036	$160,859,281
4	UTHR	UNITED THERAPEUTICS Corp	236,729	$140,375,559
5	HIMS	Hims & Hers Health, Inc.	4,151,638	$86,188,003
6	INDV	Indivior Pharmaceuticals, Inc.	2,192,264	$66,820,205
7	LNTH	Lantheus Holdings, Inc.	867,675	$65,813,148
8	TEVA	Teva Pharmaceutical Industries Ltd	1,877,217	$56,541,775

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,203	8,068	+2040.1%	Shares	Defined	2026-05-05
2025-12-31	$399	377	-95.1%	Shares	Defined	2026-01-29
2025-06-30	$25,226	7,762	+27.1%	Shares	Defined	2025-08-14
2025-03-31	$12,639	6,106	-41.3%	Shares	Defined	2025-05-13
2024-12-31	$49,333	10,408	-95.1%	Shares	Sole	2025-02-14
2024-09-30	$50,253	212,039	+517068.3%	Shares	Sole	2024-11-14
2024-03-31	$14	41	-40.6%	Shares	Sole	2024-05-13
2023-09-30	$48	69	-97.4%	Shares	Sole	2023-11-09
2023-03-31	$2,831	2,622	+215.5%	Shares	Sole	2023-05-12
2022-12-31	$1,678	831	-85.7%	Shares	Sole	2023-02-08
2022-09-30	$38,225	5,797	+19.3%	Shares	Sole	2022-11-10
2021-09-30	$8,506	4,861	+120.0%	Shares	Sole	2021-11-15
2021-06-30	$7,027	2,210	+178.7%	Shares	Sole	2021-08-13
2021-03-31	$2,616	793	—	Shares	Sole	2021-05-12
No filing history on record for this holder in this stock.